Macrophage PPAR gamma Co‐activator‐1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid. Issue 9 (21st August 2013)
- Record Type:
- Journal Article
- Title:
- Macrophage PPAR gamma Co‐activator‐1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid. Issue 9 (21st August 2013)
- Main Title:
- Macrophage PPAR gamma Co‐activator‐1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid
- Authors:
- McCarthy, Cathal
Lieggi, Nora T.
Barry, Denis
Mooney, Declan
de Gaetano, Monica
James, William G.
McClelland, Sarah
Barry, Mary C.
Escoubet‐Lozach, Laure
Li, Andrew C.
Glass, Christopher K
Fitzgerald, Desmond J.
Belton, Orina - Abstract:
- <abstract abstract-type="main" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="emmm201302587-sec-0001" sec-type="section"> <p>Conjugated linoleic acid (CLA) has the unique property of inducing regression of pre‐established murine atherosclerosis. Understanding the mechanism(s) involved may help identify endogenous pathways that reverse human atherosclerosis. Here, we provide evidence that CLA inhibits foam cell formation via regulation of the nuclear receptor coactivator, peroxisome proliferator‐activated receptor (PPAR)‐γ coactivator (PGC)‐1α, and that macrophage PGC‐1α plays a role in atheroprotection <italic>in vivo</italic>. PGC‐1α was identified as a hub gene within a cluster in the aorta of the apoE<sup>−/−</sup> mouse in the CLA‐induced regression model. PGC‐1α was localized to macrophage/foam cells in the murine aorta where its expression was increased during CLA‐induced regression. PGC‐1α expression was also detected in macrophages in human atherosclerosis and was inversely linked to disease progression in patients with the disease. Deletion of PGC‐1α in bone marrow derived macrophages promoted, whilst over expression of the gene inhibited foam cell formation. Importantly, macrophage specific deletion of PGC‐1α accelerated atherosclerosis in the LDLR<sup>−/−</sup> mouse <italic>in vivo</italic>. These novel data support a functional role for PGC‐1α in atheroprotection.</p> </sec> </abstract>
- Is Part Of:
- EMBO molecular medicine. Volume 5:Issue 9(2013:Sep.)
- Journal:
- EMBO molecular medicine
- Issue:
- Volume 5:Issue 9(2013:Sep.)
- Issue Display:
- Volume 5, Issue 9 (2013)
- Year:
- 2013
- Volume:
- 5
- Issue:
- 9
- Issue Sort Value:
- 2013-0005-0009-0000
- Page Start:
- 1443
- Page End:
- 1457
- Publication Date:
- 2013-08-21
- Subjects:
- Molecular biology -- Periodicals
Medical genetics -- Periodicals
Pathology, Molecular -- Periodicals
616.04205 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1757-4684 ↗
http://www3.interscience.wiley.com/journal/120756871/home ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/emmm.201302587 ↗
- Languages:
- English
- ISSNs:
- 1757-4676
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3681.xml